Clinical Trial Update: A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLC [Phase 3]

View source ↗

Summary

Phase III study evaluating HLX10 in combination with chemotherapy for extensive-stage small cell lung cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (unspecified regimen)
• HLX10

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Extensive Stage Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2025-12-09